E*TRADE from Morgan Stanley · 4 months ago
Institutional Equity Derivatives Sales – Analyst/Associate
E*TRADE from Morgan Stanley is a global leader in the origination, distribution, and trading of equity derivatives. The role involves supporting and growing the institutional derivatives business, collaborating with internal partners to deliver integrated solutions, and enhancing client engagement across various channels.
BankingFinanceFinancial Services
Responsibilities
Support and grow the institutional derivatives business across the West Coast, with a focus on strategic client coverage and revenue generation
Collaborate with internal partners across Trading, Structuring, Advisory and Private Wealth Management to deliver integrated solutions to clients
Work across institutional and wealth channels to enhance client engagement and expand the reach of our derivatives platform
Contribute to the distribution of ideas, trading axes, and execution across a broad suite of products including listed and OTC options, custom equity baskets, QIS, exotics, dispersion, and structured solutions
Drive initiatives to improve consistency, scalability, and client engagement across the platform
Qualification
Required
1–4 years of experience in institutional sales, trading, structuring, or a related role
Strong quantitative, analytical, and problem-solving skills
Entrepreneurial mindset with the ability to work autonomously and take ownership
Excellent communication and interpersonal skills; ability to build trust with clients and internal stakeholders
Passion for markets and a desire to grow within a high-performance team
Preferred
Experience or interest in bridging institutional and private wealth channels is a plus
Benefits
Commission earnings
Incentive compensation
Discretionary bonuses
Other short and long-term incentive packages
Other Morgan Stanley sponsored benefit programs
Company
E*TRADE from Morgan Stanley
E*TRADE from Morgan Stanley is a pioneer in the online brokerage industry.
Funding
Current Stage
Public CompanyTotal Funding
unknown2020-02-20Acquired
1996-08-16IPO
Recent News
2025-11-07
2025-10-14
Company data provided by crunchbase